The in vivo regulation of pulsatile insulin secretion

Diabetologia

Volumn 45, Issue 1, 2002, Pages 3-20

  Porksen N ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

C peptide; Diabetes; Insulin; Physiology; Pulsatility oscillation; Regulation; Secretion

Indexed keywords

INSULIN;

IN VIVO STUDY; INSULIN BLOOD LEVEL; INSULIN METABOLISM; INSULIN RELEASE; INSULIN RESPONSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OSCILLATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; CIRCADIAN RHYTHM; DIABETES MELLITUS, TYPE 2; HOMEOSTASIS; HUMANS; INSULIN; ISLETS OF LANGERHANS;

EID: 0011648510     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s125-002-8240-x     Document Type: Review

References (168)

1. Oscillations in the blood sugar of fasting normal persons
2. Fluctuations in postabsorptive blood glucose in relation to insulin relase
3. Synchronous, sustained oscillation of C-peptide and insulin in the plasma of fasting monkeys
4. Pulsatile, synchronous basal insulin and glucagon secretion in man
5. Cyclic oscillations of basal plasma glucose and insulin concentrations in human beings
6. Insulin, glucagon, and glucose exhibit synchronous, sustained oscillations in fasting monkeys
7. Hepatic glucose production oscillates in synchrony with the islet secretory cycle in fasting rhesus monkeys
8. Comparison of insulin and glucagon pulsatile secretion between the rat and dog pancreas in-vitro
9. Sustained oscillations of insulin, glucagon, and somatostatin from the isolated canine pancreas during exposure to a constant glucose concentration
10. Greater in vivo than in vitro pulsatility of insulin secretion with synchronized insulin and somatostatin secretory pulses
11. Islet somatostatin-microvascular, paracrine, and pulsatile regulation
12. Augmented effect of short-term pulsatile versus continuous insulin delivery on lipid metabolism but similar effect on whole- body glucose metabolism in obese subjects
13. Association between insulin secretory pulse frequency and peripheral insulin action in NIDDM and normal subjects
14. Altered pulsatile insulin secretion associated with endurance training
15. Body fat distribution and peripheral insulin sensitivity in healthy men: Role of insulin pulsatility
16. Pulsatile insulin delivery has greater metabolic effects than continuous hormone administration in man: Importance of pulse frequency
17. Metabolic effects of pulsatile insulin infusion in the elderly
18. Greater efficacy of pulsatile insulin in type I diabetics critically depends on plasma glucagon levels
19. Pulsatile insulin delivery: Physiology and clinical implications
20. Effects of prolonged pulsatile hyperinsulinemia in humans. Enhancement of insulin sensitivity
21. Glucose uptake and pulsatile insulin infusion: Euglycaemic clamp and [3-3H]glucose studies in healthy subjects
22. Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients
23. Efficacy of pulsatile versus continuous insulin administration on hepatic glucose production and glucose utilization in type I diabetic humans
24. Pulsatile insulin has greater hypoglycemic effect than continuous delivery
25. Rapid reduction and return of surface insulin receptors after exposure to brief pulses of insulin in perifused rat hepatocytes
26. Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting
27. Effects of glucose ingestion versus infusion on pulsatile insulin secretion. The incretin effect is achieved by amplification of insulin secretory burst mass
28. Effects of somatostatin on pulsatile insulin secretion: Elective inhibition of insulin burst mass
29. IGF-I inhibits burst mass of pulsatile insulin secretion at supraphysiological and low IGF-I infusion rates
30. Coordinate pulsatile insulin secretion by chronic intraportally transplanted islets in the isolated perfused rat liver
31. Differential effects of glucose stimulation upon rapid pulses and ultradian oscillations of insulin secretion
32. Mechanisms of sulfonylurea's stimulation of insulin secretion in vivo: Selective amplification of insulin secretory burst mass
33. Influence of nutritional state on periodicity in plasma insulin levels in monkeys
34. Glucagon-like peptide 1 increases mass but not frequency or orderliness of pulsatile insulin secretion
35. In humans at least 75% of insulin secretion arises from punctuated insulin secretory bursts
36. Disorderly and nonstationary insulin secretion in relatives of patients with NIDDM
37. Brief, irregular oscillations of basal plasma insulin and glucose concentrations in diabetic man
38. Prevention of diabetes does not completely prevent insulin secretory defects in the ZDF rat
39. Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat
40. Pulsatile insulin delivery is more efficient than continuous infusion in modulating islet cell function in normal subjects and patients with type 1 diabetes
41. Loss of regular oscillatory insulin secretion in islet cell antibody positive non-diabetic subjects
42. Decreased insulin- and glucagon-pulse amplitude accompanying beta-cell deficiency induced by streptozocin in baboons
43. Impaired pulsatile secretion of insulin in relatives of patients with non-insulin-dependent diabetes
44. Alterations in the ultradian oscillations of insulin secretion and plasma glucose in aging
45. Seminars in Medicine of the Beth Israel Hospital, Boston. Non-insulin-dependent diabetes mellitus - A genetically programmed failure of the beta cell to compensate for insulin resistance
46. Lack of control by glucose of ultradian insulin secretory oscillations in impaired glucose tolerance and in non-insulin- dependent diabetes mellitus
47. Insulin secretion in insulin-resistant women with a history of gestational diabetes
48. Insulin secretory defects in polycystic ovary syndrome. Relationship to insulin sensitivity and family history of non- insulin-dependent diabetes mellitus
49. Abnormalities in the ultradian oscillations of insulin secretion and glucose levels in Type II (non-insulin-dependent) diabetic patients
50. Ultradian oscillations of plasma glucose, insulin, and C-peptide in man during continuous enteral nutrition
51. Entrainment of pulsatile insulin secretion by oscillatory glucose infusion
52. 24-Hour glucose profiles during continuous or oscillatory insulin infusion. Demonstration of the functional significance of ultradian insulin oscillations
53. Alterations in the patterns of insulin secretion before and after diagnosis of IDDM
54. Circadian modulation of glucose and insulin responses to meals: Relationship to cortisol rhythm
55. Modulation of glucose regulation and insulin secretion by circadian rhythmicity and sleep
56. Oscillations in insulin secretion during constant glucose infusion in normal man: Relationship to changes in plasma glucose
57. Abnormal patterns of insulin secretion in non-insulin-dependent diabetes mellitus
58. Twenty-four-hour profiles and pulsatile patterns of insulin secretion in normal and obese subjects
59. Superior efficacy of pulsatile versus continuous hormone exposure on hepatic glucose production in vitro
60. Insulin oscillations perse do not affect glucose turnover parameters in normal man
61. Physiological implications of pulsatile hormone secretion
62. Insulin resistance and insulin pulsatility in essential hypertension
63. Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals
64. Increased disorderliness of basal insulin release, attenuated insulin secretory burst mass, and reduced ultradian rhythmicity of insulin secretion in older individuals
65. Insulin removal in man: In vivo evidence for a receptor-mediated process
66. Hepatic removal of insulin in normal man: Dose response to endogenous insulin secretion
67. Glucose ingestion in dogs alters the hepatic extraction of insulin
68. The effect of ingestion of meat on hepatic extraction of insulin and glucagon and hepatic glucose output in conscious dogs
69. Impact of sampling technique on appraisal of pulsatile insulin secretion by deconvolution and cluster analysis
70. In vivo synchronous membrane potential oscillations in mouse pancreatic beta-cells: Lack of co-ordination between islets
71. In vivo pulsatility of pancreatic islet peptides
72. Direct measurement of pulsatile insulin secretion from the portal vein in human subjects
73. Pulsatile insulin-secretion into the portal vein in liver cirrhosis
74. Analytical problems in detecting rapid insulin secretory pulses in normal humans
75. Oscillatory insulin secretion after pancreas transplant
76. Neural influences on oscillations in basal plasma levels of insulin in monkeys
77. Proinsulin, insulin, and C- peptide concentrations in human portal and peripheral blood
78. Glucose ingestion in dogs alters the hepatic extraction of insulin. In vivo evidence for a relationship between biologic action and extraction of insulin
79. Measurement using tracers of steady-state turnover and metabolic clearance of insulin in dogs
80. Splanchnic and renal metabolism of insulin in human subjects: A dose- response study
81. Insulin degradation: Mechanisms, products, and significance
82. Metabolism of C-peptide in the dog. In vivo demonstration of the absence of hepatic extraction
83. Estimation of insulin secretion rates from C- peptide levels. Comparison of individual and standard kinetic parameters for C- peptide clearance
84. High- frequency oscillations in circulating amylin concentrations in healthy humans
85. Plasma proinsulin in first-degree relatives of type 2 diabetic subjects
86. Hyperproinsulinemia and amyloid in NIDDM. Clues to etiology of islet beta-cell dysfunction?
87. Effect of pancreas transplantation and immunosuppression on proinsulin secretion
88. Islet hormone pulse intervals are dependent upon sampling frequency
89. Cluster analysis: A simple, versatile, and robust algorithm for endocrine pulse detection
90. Temporal pattern of pancreatic insulin and C-peptide secretion and of plasma glucose levels after nutritional stimulation
91. Insulin secretory profiles and C-peptide clearance kinetics at 6 months and 2 years after kidney-pancreas transplantation
92. Approximate entropy as a measure of system complexicity
93. A recipe for randomness
94. Quantification of hormone pulsatility via an approximate entropy algorithm
95. Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release
96. Older males secrete luteinizing hormone and testosterone more irregularly, and jointly more asynchronously, than younger males
97. Increased disorderliness and amplified basal and pulsatile aldosterone secretion in patients with primary aldosteronism
98. Greater disorderliness of ACTH and cortisol release accompanies pituitary-dependent Cushing's disease
99. Patients with Cushing's disease secrete adrenocorticotropin and cortisol jointly more asynchronously than healthy subjects
100. The pituitary gland secretes in bursts: Appraising the nature of glandular secretory impulses by simultaneous multiple-parameter deconvolution of plasma hormone concentrations
101. In vitro pancreatic hormonal pulses are less regular and more frequent than in vivo
102. Pulsatile insulin secretion in isolated rat islets
103. Preservation of insulin release periodicity from individual islets of obese Zucker rats
104. Widespread synchronous [Ca2 +]i oscillations due to bursting electrical activity in single pancreatic islets
105. Oscillations in cytosolic free Ca2+, oxygen consumption, and insulin secretion in glucose-stimulated rat pancreatic islets
106. Isolated islets of Langerhans have slow oscillations of electrical activity
107. Oscillations of lactate released from islets of Langerhans: Evidence for oscillatory glycolysis in beta-cells
108. Slow and fast oscillations of cytoplasmic Ca2 + in pancreatic islets correspond to pulsatile insulin release
109. Glucose induces oscillatory Ca2+ signalling and insulin release in human pancreatic beta cells
110. Cytoplasmic Ca2+ oscillations in pancreatic beta-cells
111. Propagation of cytoplasmic Ca2 + oscillations in clusters of pancreatic beta-cells exposed to glucose
112. Are metabolic oscillations responsible for normal oscillatory insulin secretion?
113. A mathematical model of oscillatory insulin secretion
114. Contributions of modeling to understanding stimulus-secretion coupling in pancreatic beta-cells
115. Glucose-induced oscillatory insulin secretion in perifused rat pancreatic islets and clonal beta-cells (HIT)
116. Perturbation of insulin oscillations by nerve blockade in the in vitro canine pancreas
117. Pulsatile insulin release from mouse islets occurs in the absence of stimulated entry of Ca2+
118. Glucose-induced amplitude regulation of pulsatile insulin secretion from individual pancreatic islets
119. Pulsatile insulin secretion from isolated human pancreatic islets
120. Pulsatile insulin release and electrical activity from single ob/ob mouse islets of Langerhans
121. Oscillations of circulating plasma insulin concentrations in the rat
122. Enzyme immunoassay for intact human insulin in serum or plasma
123. Electrophysiology of stimulus-secretion coupling in human beta-cells
124. Islets of Langerhans generate wavelike electric activity modulated by glucose concentration
125. Synchronous oscillations of cytoplasmic Ca2+ and insulin release in glucose-stimulated pancreatic islets
126. Electrophysiological evidence for coupling between beta cells of pancreatic islets
127. Influence of membrane potential changes on cytoplasmic Ca2+ concentration in an electrically excitable cell, the insulin- secreting pancreatic B-cell
128. Fluorescence digital image analysis of glucose-induced [Ca2 + ]i oscillations in mouse pancreatic islets of Langerhans
129. Role of intrapancreatic ganglia in regulation of periodic insular secretions
130. Effect of nerve blockade on pulsatile insulin and glucagon secretion in vitro
131. Control of pulsatile insulin secretion in man
132. A morphologic study of intrahepatic portal-vein islet isografts
133. Reinnervation of transplanted pancreatic islets, A comparison among islets implanted into the kidney, spleen, and liver
134. Effects of galanin on the release of insulin, glucagon and somatostatin from the isolated, perfused dog pancreas
135. Neural control of insulin secretion: Interaction of norepinephrine and acetylcholine
136. Effects of acute alpha 2-blockade on insulin action and secretion in humans
137. Effects of gamma-aminobutyric acid on insulin, glucagon, and somatostatin release from isolated perfused dog pancreas
138. Inhibition of insulin release from rat pancreatic islets by drugs that are analogues of dopamine
139. Central nervous system nitric oxide synthase activity regulates insulin secretion and insulin action
140. Involvement of capsaicin-sensitive nerves in regulation of insulin secretion and glucose tolerance in conscious mice
141. Lack of feedback inhibition of insulin secretion in denervated human pancreas
142. The pancreatic beta-cell as a fuel sensor: An electrophysiologist's viewpoint
143. Malonyl-CoA and long chain acyl-CoA esters as metabolic coupling factors in nutrient-induced insulin secretion
144. Deficiency of phosphofructo-1-kinase/muscle subtype in humans is associated with impairment of insulin secretory oscillations
145. Glucose entrainment of high-frequency plasma insulin oscillations in control and type 2 diabetic subjects
146. Concordant induction of rapid in vivo pulsatile insulin secretion in healthy humans by recurrent punctuated glucose infusions
147. Long-term exposure of rat pancreatic islets to fatty acids inhibits glucose- induced insulin secretion and biosynthesis through a glucose fatty acid cycle
148. Fatty acids, lipotoxicity and insulin secretion
149. Splanchnic insulin dynamics and secretion pulsatilities in abdominal obesity
150. Irregular circulating insulin concentrations in type 2 diabetes mellitus: An inverse relationship between circulating free fatty acid and the disorderliness of an insulin time series in diabetic and healthy individuals
151. Rapid oscillations in omental lipolysis are independent of changing insulin levels in vivo
152. Oscillating concentrations of free fatty acids independent of insulin and glucose oscillations
153. Hypothalamic regulation of pulsatile thyrotopin secretion
154. Negative feedback regulation of pulsatile growth hormone secretion by insulin-like growth factor I. Involvement of hypothalamic somatostatin
155. Twenty-four-hour rhythms of plasma catecholamines and their relation to cardiovascular parameters in healthy young men
156. Time series prediction of plasma hormone concentration. Evidence for differences in predictability of parathyroid hormone secretion between osteoporotic patients and normal controls
157. Rapid oscillations in plasma glucagon-like peptide-1 (GLP-1) in humans: Cholinergic control of GLP-1 secretion via muscarinic receptors
158. Ultradian oscillations of leptin secretion in humans
159. Pancreatic beta-cells are rendered glucose-competent by the insulinotropic hormone glucagon-like peptide-1(7-37)
160. Angiotensin II affects basal, pulsatile, and glucose-stimulated insulin secretion in humans
161. Repaglinide amplifies insulin secretory burst mass without affecting burst frequency
162. Treatment with the oral antidiabetic agent troglitazone improves beta cell responses to glucose in subjects with impaired glucose tolerance
163. Physiological importance of first-phase insulin release in elderly patients with diabetes
164. Glucose pulse induction markedly improves detection of a disrupted oscillatory insulin secretion in Type II diabetes
165. Pancreatic endocrine function in recipients of segmental and whole pancreas transplantation
166. Oscillatory insulin secretion: A variable phenotypic marker
167. Insulin pulsatility in obese and normal prepubertal children
168. Effect of insulin sensitivity on pulsatile insulin secretion